World's Leading Opinion Leaders from India

advance in management of patients with STEMI. I particularly think that young patients with STEMI who have a very high thrombotic load will derive the greatest benefit from this stent.” I have used MGuard in patients with Acute Coronary syndrome. Most of the lesions were thrombus containing. I found it is effective against distal embolization and it enhances the achievement of optimal myocardial perfusion. “Based on my current clinical experience the MGuard stent appears to be superior to any other devices in overcoming the distal embolisation in highly thrombotic lesions.” “The MGuard device shows excellent performance in highly complex lesions. In our preliminary experience there was an absence of angiographic and procedural complications. It can solve or control the problem of friable plaques and thrombus.” “MGuard is quite an innovative stent and is extremely effective in trapping thrombus and soft plaque as is seen in acute MI and Saphenous Vein Graft. In many cases it may be invaluable for preventing distal embolization.” “I find MGuard stents to be extremely useful in thrombus laden vessels. The chances of slow or No flow are minimized with very good TIMI flow in primary Acute STEMI”.